Erschienen in:

01.07.2006 | Preclinical Studies

Binding of gefitinib, an inhibitor of epidermal growth factor receptor-tyrosine kinase, to plasma proteins and blood cells: in vitro and in cancer patients

verfasst von: Jing Li, Julie Brahmer, Wells Messersmith, Manuel Hidalgo, Sharyn D. Baker

Erschienen in: Investigational New Drugs | Ausgabe 4/2006